n(4)-hydroxycytidine has been researched along with PF-00835231 in 1 studies
| Studies (n(4)-hydroxycytidine) | Trials (n(4)-hydroxycytidine) | Recent Studies (post-2010) (n(4)-hydroxycytidine) | Studies (PF-00835231) | Trials (PF-00835231) | Recent Studies (post-2010) (PF-00835231) |
|---|---|---|---|---|---|
| 42 | 1 | 32 | 10 | 0 | 9 |
| Protein | Taxonomy | n(4)-hydroxycytidine (IC50) | PF-00835231 (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 0.004 | |
| Calpain-1 catalytic subunit | Homo sapiens (human) | 0.4837 | |
| Procathepsin L | Homo sapiens (human) | 0.3992 | |
| Cathepsin B | Homo sapiens (human) | 0.8102 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 0.0053 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.1364 | |
| Cathepsin K | Homo sapiens (human) | 0.4837 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caaveiro, JMM; Hamada, R; Hiramoto, T; Hirose, Y; Isogai, H; Kawanishi, E; Matsunaga, N; Mori, M; Ochi, J; Ohdo, S; Ojida, A; Onitsuka, S; Orba, Y; Sasaki, M; Sato, A; Sawa, H; Shindo, N; Takahashi, D; Toba, S; Ueda, T; Yoshida, Y | 1 |
1 other study(ies) available for n(4)-hydroxycytidine and PF-00835231
| Article | Year |
|---|---|
Discovery of Chlorofluoroacetamide-Based Covalent Inhibitors for Severe Acute Respiratory Syndrome Coronavirus 2 3CL Protease.
Topics: Antiviral Agents; Coronavirus 3C Proteases; COVID-19 Drug Treatment; Cysteine; Cysteine Endopeptidases; Humans; Peptide Hydrolases; Peptides; Protease Inhibitors; SARS-CoV-2 | 2022 |